Failure to Demonstrate Plasma Hormone Abnormalities in Women with Operable Breast Cancer
The endocrine profile of patients with breast cancer has been the object of extensive studies during the past several years. Abnormal secretion of a variety of hormones has been described on different occasions in patients with breast cancer (Gambrell, 1982; Henderson et al., 1982; Kirschner et al., 1982; Kwa and Wang, 1977; Ohgo et al., 1976), and has been considered a possible risk factor. However, conclusive evidence has not yet been presented to show that the cancer patients are significantly different in endogenous hormone profiles from their healthy counterparts. The main purpose of the present study was to critically reevaluate this controversial issue and possibly identify hormonal changes in a large population of patients with operable breast cancer not present in a comparable population of normal healthy women.
KeywordsBreast Cancer Breast Cancer Patient Luteinizing Hormone Follicle Stimulate Hormone Thyroid Stimulate Hormone
Unable to display preview. Download preview PDF.
- Bruning, P.F., Bonfrer, H., Dejong-Bakker, M., Hart, A. A. M., and Kwa, H. G., 1983, Prolactin and steroid hormones in premenopausal women at risk for breast cancer, Proc. 3rd EORTC Breast Cancer Working Conf., Amsterdam, April 27–29.Google Scholar
- Grattarola, R., Secreto, G., and Recchione, C., 1975, Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgen activity, Am. J. Obst. Gynecol., 118: 173.Google Scholar
- Henderson, B. E., Ross, R. K., and Pike, M. C., 1982, Endogenous hormones as a major factor in human breast cancer, Cancer Res. (suppl. 8 ), 42: 3232.Google Scholar
- Horwitz, K. B., McGuire, W. L., Pearson, O. H., and Segaloff, A., 1975, Predicting response to endocrine therapy in human breast cancer. A hypothesis. Science, 189: 726.Google Scholar
- Kirschner, M. A., Schneider, G., and Ertel, N. H., 1982, Obesity, androgens, estrogens and cancer risk, Cancer Res., (suppl. 8 ), 42: 3281.Google Scholar
- Malarkey, W. B., Schroeder, L. L., Stevens, V. C., James, A. G., and Lanese, R. R., 1977, Twenty-four hour preoperative endocrine profiles in women with benign and malignant breast disease, Cancer Res., 37: 46–55.Google Scholar
- McGuire, W. R., Carbone, P. P., Seans, M. E., and Escher, G. C., 1975, Estrogen receptor in human breast cancer. An overview, in:“Estrogen receptors in human breast cancer”, W.L. Mc Guire, P. P. Carbone, E. P. Wollmer, eds., Raven Press, New York, N. Y.Google Scholar
- Sherman, B. M., and Korenman, S. G.,1974, Inadeguate corpus luteum function. A pathophysiological interpretation of human breast cancer epidemiology, Cancer, 33: 1306.Google Scholar
- Smethutst, M., Alexander, K., and Williams, D. C., 1975, Plasma progestrerone levels in postmenopausal women with breast cancer. IRCS Medical Science. Cancer, endocrine system, metabolism and nutrition, Obstet. Gynecol., 3: 89.Google Scholar